Officers
Patricia M. LoRusso, DO, PhD (hc), FAACR
(2024-2025)Associate Center Director of Experimental Therapeutics
Director, Early Therapeutics Disease‐Aligned Research Teams
Yale Cancer Center
Professor of Medicine
Yale University
New Haven, Connecticut
Lillian L. Siu, MD, FAACR
(2024-2025)Director, Phase I Clinical Trials Program
Codirector, Robert and Maggie Bras and Family Drug Development Program
Clinical Lead, Tumor Immunotherapy Program
BMO Chair, Precision Cancer Genomics
Princess Margaret Cancer Centre
Professor of Medicine
University of Toronto
Toronto, Canada
Philip D. Greenberg, MD, FAACR
(2024-2025)Rona Jaffe Foundation Endowed Chair and Professor and Head of the Program in Immunology
Fred Hutchinson Cancer Research Center
Professor, Medicine and Immunology
University of Washington School of Medicine
Seattle, Washington
Margaret Foti, PhD, MD (hc)
American Association for Cancer Research
Philadelphia, Pennsylvania
William N. Hait, MD, PhD, FAACR
(2022-2025)Executive Vice President
Chief External Innovation, Medical Safety and Global Public Health Officer
Johnson & Johnson